YETI Holdings
YETI
Halozyme Therapeutics
HALO
eBay
EBAY
4
Constellation Brands
STZ
5
Workday
WDAY
(Q2)Apr 4, 2025 | (Q1)Jan 3, 2025 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 28, 2024 | (Q2)Mar 29, 2024 | (Q1)Jan 3, 2024 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 28, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 112.53%38.69M | 101.39%66.66M | -2.56%162.64M | 23.78%62.33M | 6.97%49.01M | -43.95%18.2M | 33.1M | -5.69%166.92M | -16.07%50.35M | 13.43%45.82M |
Net income from continuing operations | 111.39%31.67M | -1,437.46%-167.53M | -16.07%76.86M | 20.30%29.41M | 68.22%19.94M | -41.84%14.98M | --12.53M | -79.18%91.58M | -89.78%24.45M | -63.23%11.85M |
Operating gains losses | --0 | --193.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -13.91%14.81M | 11.94%16M | 28.95%67.25M | 29.79%17.83M | 37.42%17.93M | 37.47%17.2M | --14.29M | -8.87%52.15M | -3.10%13.74M | -6.60%13.05M |
Deferred tax | 3.14%3.52M | -2,231.29%-6.27M | -75.01%4.95M | 77.62%-1.71M | -59.03%2.95M | -69.44%3.41M | --294K | 109.88%19.8M | 96.23%-7.63M | 771.43%7.2M |
Other non cash items | 162.79%678K | -72.59%-3.03M | 35.20%6.53M | 35.10%2.01M | -1.76%6.02M | 110.74%258K | ---1.76M | 663.35%4.83M | 364.12%1.49M | 30,545.00%6.13M |
Change In working capital | -3.41%-30.75M | 1,072.70%8.87M | -11.76%-31.03M | -58.26%5.06M | -168.51%-5.45M | -23.82%-29.73M | ---912K | 40.53%-27.77M | 997.26%12.13M | 146.76%7.95M |
-Change in receivables | -107.19%-39.67M | 222.71%14.95M | -237.15%-16.81M | -92.64%1.08M | -15.59%13.45M | -144.63%-19.15M | ---12.18M | 172.16%12.25M | 190.30%14.64M | 363.68%15.93M |
-Change in inventory | 25.43%-10.35M | -396.46%-4.61M | -185.95%-30.23M | -412.70%-5.12M | -221.70%-12.78M | -645.84%-13.88M | --1.56M | 67.24%-10.57M | 134.62%1.64M | 76.46%-3.97M |
-Change in prepaid assets | -16.11%-4M | 41.18%-300K | 467.13%3.41M | 119.50%4.38M | 4,619.70%2.98M | -49.72%-3.45M | ---510K | -116.67%-928K | -57.28%2M | -122.00%-66K |
-Change in payables and accrued expense | 149.43%20.47M | -145.58%-3.98M | 138.88%10.91M | 130.74%2.25M | -174.32%-8.28M | 174.16%8.21M | --8.73M | -760.28%-28.05M | -54.36%-7.3M | -163.28%-3.02M |
-Change in other working capital | 291.34%2.81M | 89.12%2.82M | 454.62%1.69M | 113.95%2.48M | 11.28%-818K | -52.65%-1.47M | --1.49M | -295.88%-476K | 172.47%1.16M | -209.24%-922K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 112.53%38.69M | 101.39%66.66M | -2.56%162.64M | 23.78%62.33M | 6.97%49.01M | -43.95%18.2M | --33.1M | -5.69%166.92M | -16.07%50.35M | 13.43%45.82M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -140.29%-156.91M | 70.59%-10.23M | -598.43%-181.13M | -126.29%-32.52M | 22.19%-48.54M | -283.62%-65.3M | -34.77M | 119.87%36.34M | 274.10%123.7M | -70.48%-62.39M |
Net PPE purchase and sale | -59.03%-8.16M | -14.79%-5.34M | -34.42%-22.44M | 10.69%-5.19M | -128.37%-7.47M | -356.24%-5.13M | ---4.65M | 36.98%-16.69M | 24.51%-5.81M | 50.69%-3.27M |
Net business purchase and sale | -212.30%-210K | 83.37%-12.47M | 17.19%-72.62M | --0 | 105.96%2.2M | 100.37%187K | ---75M | -168.64%-87.69M | --0 | ---36.86M |
Net investment purchase and sale | -138.52%-143.96M | -75.52%10.99M | -158.09%-81.75M | -119.42%-25.15M | -84.74%-41.13M | -289.73%-60.36M | --44.88M | 149.53%140.73M | 304.41%129.51M | 25.71%-22.26M |
Net other investing changes | ---4.58M | ---3.4M | ---4.33M | ---2.18M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -140.29%-156.91M | 70.59%-10.23M | -598.43%-181.13M | -126.29%-32.52M | 22.19%-48.54M | -283.62%-65.3M | ---34.77M | 119.87%36.34M | 274.10%123.7M | -70.48%-62.39M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -190.48%-3.84M | 432.76%30.13M | 93.92%-9.06M | 99.48%-630K | 12.32%1.94M | 74.51%-1.32M | -9.05M | -415.50%-149.02M | -40,443.48%-121.23M | 14.20%1.73M |
Net issuance payments of debt | 23.73%-270K | 24,856.73%86.4M | 98.83%-1.43M | 99.70%-369K | -20.07%-359K | -13.10%-354K | ---349K | -12,645.56%-121.98M | -52,317.75%-121.09M | -32.30%-299K |
Net common stock issuance | ---- | ---- | 56.41%-14.22M | -144.29%-342K | ---- | ---- | ---- | 9.40%-32.62M | -105.88%-140K | ---- |
Proceeds from stock option exercised by employees | -245.92%-3.35M | -283.40%-33.37M | 18.16%6.59M | --81K | -53.12%16.18M | 96.90%-969K | ---8.7M | -30.77%5.57M | --0 | 1,082.96%34.51M |
Net other financing activities | ---221K | ---22.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -190.48%-3.84M | 432.76%30.13M | 93.92%-9.06M | 99.48%-630K | 12.32%1.94M | 74.51%-1.32M | ---9.05M | -415.50%-149.02M | -40,443.48%-121.23M | 14.20%1.73M |
Net cash flow | ||||||||||
Beginning cash position | 42.25%232.7M | -15.61%146.81M | 45.02%173.95M | -3.47%117.3M | -15.80%114.99M | 29.67%163.59M | --173.95M | -23.37%119.95M | -8.06%121.52M | 7.05%136.57M |
Current changes in cash | -152.10%-122.06M | 906.83%86.56M | -150.81%-27.56M | -44.77%29.18M | 116.23%2.41M | -571.87%-48.42M | ---10.73M | 255.91%54.24M | 565.14%52.83M | -379.60%-14.84M |
Effect of exchange rate changes | 263.28%289K | -283.43%-664K | 272.69%411K | 180.45%321K | 54.55%-95K | -212.74%-177K | --362K | 86.76%-238K | 53.60%-399K | 70.73%-209K |
End cash Position | -3.53%110.93M | 42.25%232.7M | -15.61%146.81M | -15.61%146.81M | -3.47%117.3M | -15.80%114.99M | --163.59M | 45.02%173.95M | 45.02%173.95M | -8.06%121.52M |
Free cash flow | 133.53%30.53M | 115.56%61.32M | -1.42%140.2M | 28.28%57.14M | -2.35%41.54M | -50.62%13.07M | --28.45M | -5.48%142.22M | -14.82%44.55M | 26.01%42.54M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |